JWGsp. j.

Dispensing chemist in specialised stores

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2015-10-06
Registered address
ul. Trzmielowicka 7/9, 54-002 Wrocław, Poland
Electronic delivery address
AE:PL-13253-91521-HSEUS-18

Financials

Revenue history (in k)

Filing timeliness

Financial statements were filed on time, on average 17 days early.

  • 202511/06/2026
  • 202423/06/2025
  • 202326/06/2024
  • 202215/07/2023
  • 202120/06/2022
  • 202015/10/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

Top 36%
Division · Retail trade2,516 / 9,938
Top 25%
City · Wrocław1,370 / 13,735
Top 10.0%
Voivodeship · Dolnośląskie2,936 / 23,951
Top 12%
Country · Poland40,134 / 298,580
Top 13%

Results vs industry

Revenue
This companyUSD 3.84mMedianUSD 1.92mAverageUSD 5.21m
Net profit
This companyUSD 480.65kMedianUSD 21.05kAverageUSD 87.01k
Operating costs
This companyUSD 3.34mMedianUSD 1.88mAverageUSD 5.05m
Assets
This companyUSD 558.74kMedianUSD 544.32kAverageUSD 1.76m

National Health Fund (NFZ) contracts

JWG has been an NFZ healthcare provider since 2025. In 2026 it is performing 1 contract worth USD 0.00. All its contracts were worth USD 0.00 in total.

NFZ contract value by year (USD)

Type of careNFZ branchContractsValue in 2026
Other services provided in pharmaciesdolnośląskie1USD 0.00

Ownership

Manner of representation

Independently.

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2011-07-01.

  • mBank
    55 1140 2004 0000 3702 7362 8173

Debt

No entries in the National Debtors Register (KRZ).

Public aid

5 public aid cases recorded, with a total value of $120,832.

PurposeGross amount
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$17,330
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$2,605
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$95,477

European Funds

ProjectEU co-financing
Funding for pharmacies
$17,330

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Competitors

Name
Cefarm RzeszówS.A.
Modrzewscysp. j.
Ms-Pharmsp. z o.o. + limited partnership
Farmjug Agsp. z o.o.
MagmaxS.A.
Adpharmasp. z o.o.
Alfa Pharm - Małgorzata Janusik, Jarosław Janusiksp. j.
Novopharm - Millersp. j.
Pikadasp. z o.o.
Vitasp. z o.o.

FAQ

Last updated: 2026-06-11